Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Bipolar Disorder Clinical Trials

100 recruiting trials for Bipolar Disorder. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
100
Total Trials
100
Recruiting Now
9
Phase 3 Trials
10
Sponsors

Recruiting Trials

RECRUITINGNCT05669703

NIMH Rhythms and Blues Study: A Prospective Natural History Study of Motor Activity, Mood States, and Bipolar Disorder

Background: Mood disorders, such as bipolar disorder, can have serious effects on a person s life. People with bipolar disorder are more likely to have heart disease and abuse...

Sponsor: National Institute of Mental Health (NIMH)Enrolling: 12601 location
RECRUITINGNCT06897670

Identifying Cerebral Hemodynamic Patterns in Mood Disorders and Mild Cognitive Impairment: A Functional Near-Infrared...

The purpose of this research is to measure brain activity in individuals with mood disorders and memory problems using a simple, safe, and noninvasive method called functional...

Sponsor: Mayo ClinicEnrolling: 2001 location
RECRUITINGNCT06370988

Theta-Burst Stimulation for Bipolar Depression

The purpose of this trial is to determine if intermittent theta-burst stimulation (iTBS) can reduce the symptoms of depression in treatment-resistant bipolar disorder. To do this,...

Sponsor: Centre for Addiction and Mental HealthEnrolling: 1242 locations
RECRUITINGNCT05698589

COMpassion for Psychiatric Disorders And Self-Stigma

People with mental disorders face frequent stigmatizing attitudes and behaviors from others . In response to this, they tend to isolate themselves, with the risk of impeding care...

Sponsor: University Hospital, Strasbourg, FranceEnrolling: 3367 locations
RECRUITINGNCT04664257

Delivering Electronic Cognitive Behavioural Therapy to Patients With Bipolar Disorder and Residual Depressive Symptoms

The lifetime prevalence of Bipolar II is 0.4% with the time spent with depressive symptoms outnumbering the time spent with hypomanic symptoms by 35 to 1. Regarding current...

Sponsor: Dr. Nazanin AlaviEnrolling: 801 location
RECRUITINGNCT06920940

Child Bipolar Network Ketogenic Diet Approach to Bipolar Disorder in Adolescents

The present study is an open trial of ketogenic diets for adolescents and young adults (ages 12-21 yrs) in the depressive or mixed phases of bipolar disorder (BD). The...

Sponsor: University of California, Los AngelesEnrolling: 804 locations
RECRUITINGPhase 3NCT06462612

Study of Lumateperone in the Treatment of Patients With Bipolar Mania

This is a multicenter, randomized, double-blind, placebo-controlled, study in the acute treatment of patients with a diagnosis of bipolar I disorder with manic episodes or manic...

Sponsor: Intra-Cellular Therapies, Inc.Enrolling: 35020 locations
RECRUITINGNCT00025935

Studies of Brain Function and Course of Illness in Pediatric Bipolar Disorder

This study seeks to learn more about the symptoms of severe mood dysregulation in children and adolescents ages 7-17. Children and adolescents with severe mood dysregulation (SMD)...

Sponsor: National Institute of Mental Health (NIMH)Enrolling: 23501 location
RECRUITINGNCT06904079

Prediction and Intervention Effect of Rehabilitation Status for Severe Mental Disorder Patients Based on Multimodal...

Mental health issues represent a major public health and social problem that significantly impacts economic and social development. Compared to other diseases, mental disorders...

Sponsor: Shanghai Mental Health CenterEnrolling: 821 location
RECRUITINGPhase 1NCT05025605

Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder

This is a study of the efficacy and safety of BXCL501 in children and adolescents with acute agitation and either bipolar disorder or schizophrenia.

Sponsor: BioXcel Therapeutics IncEnrolling: 1405 locations
RECRUITINGPhase 3NCT06229210

Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism...

This is a multicenter, global, 26-week, open-label study to assess the safety and tolerability of lumateperone in pediatric patients with schizophrenia, bipolar disorder or autism...

Sponsor: Intra-Cellular Therapies, Inc.Enrolling: 50020 locations
RECRUITINGNCT05934474

Biocollection on Peripheral Inflammation

Most psychiatric research is based on the nosographic classifications used in current practice. At present, there is no diagnostic or prognostic biomarker for psychiatric...

Sponsor: Nantes University HospitalEnrolling: 3001 location
RECRUITINGNCT06508450

A Mental Health Services Engagement Program for Racial and Ethnic Minority Young Adults

Researchers aim to test a brief culturally-responsive young adult orientation program for community mental health services. They will conduct a 24-month randomized trial with 80...

Sponsor: New York UniversityEnrolling: 801 location
RECRUITINGNCT05627492

Pragmatic Patient-oriented Extension Study of Dialectical Behavior Therapy Booster Sessions for Youth With and/or at...

The study intervention is DBT adapted for youth with and/or at familial risk for bipolar disorder. Participants will have completed one full year of DBT in a previous study. This...

Sponsor: Centre for Addiction and Mental HealthEnrolling: 1201 location
RECRUITINGNCT04184375

Cognitive Stimulation for Elderly Bipolar Patients

Age is a major risk factor for the development of cognitive disorders and neurodegenerative pathologies. Cognitive disorders during the phases of bipolar disease are known to...

Sponsor: Groupe Hospitalier de la Rochelle Ré AunisEnrolling: 401 location
RECRUITINGNCT03601026

Genetic Counselling in the Prevention of Mental Health Consequences of Cannabis Use

Severe mental illness (SMI) refers to the most burdensome psychiatric conditions. The need to pre-empt the onset of SMI is pressing because once SMI develops, quality of life is...

Sponsor: Nova Scotia Health AuthorityEnrolling: 1201 location
RECRUITINGNCT06426810

Electrosurgical Bipolar Systems Versus Conventional Electrocautery After SLNBx

The efficacy of electrosurgical bipolar systems in axillary lymph node dissection for breast cancer surgery is well known. In this study, the investigators aim to determine...

Sponsor: SMG-SNU Boramae Medical CenterEnrolling: 401 location
RECRUITINGNCT07389473

Evaluate the Effects of Long-term Use of Psychotropic Medications on Eye Movement Patterns With the Gaize Device

The study aims to verify if the Gaize ocular device can effectively identify eye movements indicative of prescribed psychotropic medication usage by employing Drug Recognition...

Sponsor: GaizeEnrolling: 501 location
RECRUITINGNCT06022913

Behavioural Activation for Bipolar Depression

Bipolar disorder (BD) affects between 1-3% of the world's population. People with BD experience episodes of mania or hypomania and in most cases, they experience periods of...

Sponsor: Reykjavik UniversityEnrolling: 101 location
RECRUITINGNCT06384755

Honest Open Proud for Psychotic and Bipolar Disorder in Norway

The purpose of this pilot study is to evaluate the feasibility, acceptability and efficacy of a Norwegian adaptation of the group-based intervention 'Honest Open Proud' among...

Sponsor: Oslo University HospitalEnrolling: 402 locations
RECRUITINGPhase 2NCT06226025

Correcting Circadian Rhythms to Breakthrough in Bipolar Disorder

The purpose of this study is to test whether a dietary supplement (low-dose melatonin) commonly used to treat night owls, administered in conjunction with a behavioral sleep...

Sponsor: Leslie SwansonEnrolling: 501 location
RECRUITINGNCT06112067

Efficacy and Safety of Combo-stim Deep Brain Stimulation for Treatment-refractory Mental Disorders

This is a multi-center, single arm, prospective, open-label, extendable study for the efficacy and safety of combo-stim deep brain stimulation for treatment-refractory mental...

Sponsor: Shanghai Mental Health CenterEnrolling: 181 location
RECRUITINGNCT06271304

Stabilizing Mood and Sleep With Blue Blocking Eyewear in Bipolar Disorder

The study investigates whether add-on treatment with eyewear that blocks the short wavelengths of visible light (\<500nm) reduces manic symptoms and improves sleep in patients...

Sponsor: Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg HospitalEnrolling: 1501 location
RECRUITINGNCT06371352

Effect of Intermittent and Continuous Theta Burst Stimulation on Sleep, Daytime Sleepiness, and Fatigue in Depression

Intermittent and continuous theta-burst stimulation (iTBS and cTBS respectively) are the newer modalities of transcranial magnetic stimulation with documented efficacy in...

Sponsor: Jakub AntczakEnrolling: 901 location
RECRUITINGNCT05223959

Culturally Adapted Psychoeducation for Bipolar Disorder in a Low-resource Setting: A Randomized Controlled Trial

Study objectives: 1. To determine the effectiveness of the CaPE intervention compared to treatment as usual (TAU) in reducing the time to recurrence for people with bipolar...

Sponsor: Pakistan Institute of Living and LearningEnrolling: 3001 location
RECRUITINGPhase 4NCT07105111

A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain...

This study will evaluate the efficacy of valbenazine on clinician- and patient-reported outcomes in participants with TD while receiving or after stopping a VMAT2 inhibitor.

Sponsor: Neurocrine BiosciencesEnrolling: 508 locations
RECRUITINGNCT07212075

Precision Subclassification of Mental Health in Diabetes: Digital Twins for Precision Mental Health to Track Subgroups

Mental conditions and disorders (e.g. distress, depressive, anxiety, and eating disorders) are more prevalent in people with diabetes (PWD) and associated with reduced quality of...

Sponsor: Forschungsinstitut der Diabetes Akademie MergentheimEnrolling: 18093 locations
RECRUITINGPhase 3NCT05603104

Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a...

Schizophrenia, bipolar and major depressive disorders collectively affect over 10 million people across the EU and are associated with annual healthcare and societal costs in...

Sponsor: Dr. Inge WinterEnrolling: 12541 location
RECRUITINGNCT06393907

Hemostatic Forceps vs. Bipolar Electrocautery Probes for High-Risk Bleeding Gastroduodenal Ulcers

A randomized controlled trial to evaluate the efficacy of hemostatic forceps and bipolar electrocautery probes in patient with high risk bleeding gastroduodenal ulcers.

Sponsor: Mahidol UniversityEnrolling: 1501 location
RECRUITINGNCT06313918

Exercise Therapy in Mental Disorders-study

The study will compare standard high-intensity training with brief high-intensity training in people with schizophrenia-spectrum or bipolar disorder. The overall aim is to...

Sponsor: Haukeland University HospitalEnrolling: 501 location
RECRUITINGPhase 3NCT03423680

A Study of Abilify® Tablet(Aripiprazole) as an Adjunctive Treatment in the Bipolar Depression

This is an 8-week, multicenter, randomized, double blind, placebo controlled study to evaluate the efficacy and safety of aripiprazole as an adjunctive treatment with mood...

Sponsor: Korea Otsuka Pharmaceutical Co., Ltd.Enrolling: 3901 location
RECRUITINGPhase 4NCT06184581

Lithium Versus Lamotrigine in Bipolar Disorder, Type II

The investigators want in a 6-month randomized controlled trial (RCT) to compare effects of lithium versus lamotrigine on mood stabilization and other critical patient outcomes in...

Sponsor: University Hospital Bispebjerg and FrederiksbergEnrolling: 2001 location
RECRUITINGNCT06624462

Effectiveness of a Pragmatic, Metabolic Care Clinic for Patients With Severe Mental Illness - The Meta Care Clinic

This study will examine the effectiveness of a Pragmatic, Metabolic Care Clinic for Patients With Severe Mental Illness

Sponsor: Bjorn H. EbdrupEnrolling: 841 location
RECRUITINGPhase 2NCT05977023

NMDA Receptor Modulation for the Treatment of Bipolar I Disorder

At present, the treatment of Bipolar I disorder (BD-I), especially its depressive episode (bipolar depression), is still limited, because there is no effective treatment for the...

Sponsor: China Medical University HospitalEnrolling: 901 location
RECRUITINGPhase 4NCT06417437

Non-invasive BCI and Application Verification for Depressed People

Major Depressive Disorder (MDD) is a serious mental illness and public health problem that poses threat to both physical and mental health. According to statistics from WHO, it is...

Sponsor: Shanghai Mental Health CenterEnrolling: 4001 location
RECRUITINGNCT06743711

Validation and Impact of Cardiorespiratory Fitness in Severe Mental Illness - the Heart in Mind Project

This project aims to evaluate feasibility, validity and clinically applicability to systematically measure fitness in patients with severe mental illness. The research project is...

Sponsor: Bjorn H. EbdrupEnrolling: 751 location
RECRUITINGPhase 2NCT05837104

Efficacy and Safety of Magnesium Vitamin B6 in First Episode Bipolar Disorder

This is a randomized, double-blind, placebo-controlled proof-of-concept clinical trial to assess the efficacy and safety of Magnesium-vitamin B6in combination with treatment as...

Sponsor: Mclean HospitalEnrolling: 401 location
RECRUITINGPhase 3NCT07172516

A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder...

X-CEED is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of azetukalner in adult participants diagnosed with...

Sponsor: Xenon Pharmaceuticals Inc.Enrolling: 40020 locations
RECRUITINGNCT05491538

Acceptability and Feasibility of Work-Oriented Social-Cognitive Skills Training for Veterans With Serious Mental Illness

Many individuals with serious mental illness have difficulty accurately interpreting interpersonal cues and effectively engaging in social exchanges. Difficulties related to the...

Sponsor: VA Office of Research and DevelopmentEnrolling: 201 location
RECRUITINGNCT06373016

Use of Ketosis in Modulating Metabolic Pathways in Bipolar Disorder

The goal of this clinical trial is to test how specific components of diet affect brain function and behavior for individuals with bipolar. The main question it aims to answer is...

Sponsor: Stony Brook UniversityEnrolling: 1003 locations
RECRUITINGNCT00201526

Bipolar Research And Innovation Network - BRAIN

To describe the broad spectrum of Bipolar Disorder patients admitted to out-patient and in-patient psychiatric departments in Norway. Include all admitted Bipolar patients both...

Sponsor: Norwegian University of Science and TechnologyEnrolling: 30001 location
RECRUITINGNCT05767073

LIVES: Personalized Lifestyle Intervention for Patients With Depression

Persons with affective disorder have a considerably increased risk of cardiovascular disease. To a considerable extent, this is due to an unhealthy life style. At present, no...

Sponsor: University Medical Center GroningenEnrolling: 382 locations
RECRUITINGNCT06729541

Development and Application of Precision Treatment Strategies for Common Mental Disorders

Schizophrenia (SCH), major depressive disorder (MDD), and bipolar disorder (BPD) are prevalent, disabling psychiatric conditions that not only cause significant suffering for...

Sponsor: Peking UniversityEnrolling: 6001 location
RECRUITINGNCT06759194

HoLEP vs BipolEP in Management of BPH Patients With Large Prostates

This is a non-inferiority prospective randomized comparative clinical trial aiming to prove the non-inferiority of bipolar enucleation of the prostate in comparison to holmium...

Sponsor: Assiut UniversityEnrolling: 981 location
RECRUITINGNCT05878730

Melatonin and Response to Lithium

Bipolar disorders are mental illnesses characterized by the recurrence of mood-episodes, that can have a severe impact on the life of individuals. The effect of lithium, one of...

Sponsor: Assistance Publique - Hôpitaux de ParisEnrolling: 601 location
RECRUITINGNCT00024635

Evaluation of Patients With Mood and Anxiety Disorders and Healthy Volunteers

The purpose of this protocol is to allow for the careful screening of patients and healthy volunteers for participation in research protocols in the Experimental Therapeutics and...

Sponsor: National Institute of Mental Health (NIMH)Enrolling: 160001 location
RECRUITINGPhase 1NCT06305598

Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration...

This phase I trial tests the change in androgen receptor sensitivity, side effects and effectiveness of bipolar androgen therapy, using testosterone, in patients with castration...

Sponsor: Roswell Park Cancer InstituteEnrolling: 141 location
RECRUITINGPhase 2NCT07288320

An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current...

The primary objective for this study is to evaluate the efficacy of NBI-1117568 compared with placebo on improving manic symptoms in adults with bipolar I disorder who are...

Sponsor: Neurocrine BiosciencesEnrolling: 1506 locations
RECRUITINGNCT06687694

Immune Mechanisms of Antipsychotic Treatment Response

The aim of this study is to investigate the role of the immune system in psychotic symptoms and their response to treatment. The investigators will collect blood and cerebrospinal...

Sponsor: King's College LondonEnrolling: 5001 location
RECRUITINGNCT03829787

Attentional Biases, Reward Sensitivity, and Cognitive Control in Adults With Bipolar Disorder

The purpose of this study is to use eye-tracking technology to study attentional biases, reward sensitivity, and cognitive control in adult patients with bipolar disorder with or...

Sponsor: University Hospitals Cleveland Medical CenterEnrolling: 1001 location

Showing 50 of 100 trials.Search all Bipolar Disorder trials